Physician

Faraz Manazir, M.D.

According to 2025 Medicare claims, Faraz Manazir, M.D. (NPI: 1104805092) practices interventional cardiology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE PLLC (NPI: 1982632907; TIN: 421085919) and primary practice location at 61265-7127. Manazir is affiliated with the IRCCO (ACO ID: A2619), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Manazir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,420 traditional Medicare patients, billed 9,912 HCPCS/CPT codes, and received $589,463 in Medicare payments. The top billing code was A9555 (Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries). Part D data shows 8,532 prescription claims across 1,368 beneficiaries totaling $972,643 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $154. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $269,741 to $972,643. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,829	10,733	$643,971
2016	2,130	10,442	$435,869
2017	2,675	12,680	$505,125
2018	2,536	11,577	$499,836
2019	2,438	14,012	$536,024
2020	2,200	13,152	$437,414
2021	2,177	13,552	$499,922
2022	1,892	10,668	$432,662
2023	1,687	10,488	$504,202
2024	1,420	9,912	$589,463

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	754	5,935	$269,741
2016	753	5,853	$350,607
2017	838	5,626	$360,305
2018	885	5,869	$407,417
2019	971	6,603	$505,361
2020	1,036	7,213	$577,325
2021	1,077	7,498	$668,568
2022	1,163	7,377	$737,453
2023	1,246	7,488	$825,748
2024	1,368	8,532	$972,643

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	206	412	$404
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	353	359	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	395	452	$84
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	430	469	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	307	365	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	450	26,292	$507,345
Entresto	Sacubitril/Valsartan	109	6,204	$139,482
Repatha Sureclick	Evolocumab	52	2,922	$56,636
Xarelto	Rivaroxaban	42	2,705	$48,635
Jardiance	Empagliflozin	43	2,365	$43,226

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$154	ShockWave Medical, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Faraz Manazir, M.D.?

Tedicare shows public-source Medicare data for Faraz Manazir, M.D. (NPI 1104805092), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Faraz Manazir, M.D. have ACO affiliation data?

Faraz Manazir, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Faraz Manazir, M.D.?

Faraz Manazir, M.D. is linked to CARDIOVASCULAR MEDICINE PLLC (billing NPI 1982632907) in the available physician profile data.

Does Faraz Manazir, M.D. have Open Payments data?

Faraz Manazir, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.